1029PResponse to pegylated liposomal doxorubicin (PLD) and weekly paclitaxel (wpac) in platinum resistant (PR) ovarian cancer (OC) by BRCA mutation status
Bremer, L C, Pate, C L, Banerjee, S, George, AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.037
Date:
October, 2019
File:
PDF, 76 KB
2019